Pregnancy outcome
- col. 1,2,3 - day, month, year of the delivery;
- col. 4 status of fetal growth restriction (FGR), 0 - FGR, 1 - no FGR (control group);
- col. 5 gestation duration (days);
- col. 6 birthweight;
- col. 7 maternal age (-1 means no data);
- col. 8 maternal BMI (-1 means no data);
- col. 9 maternal phototype (according to Fitzpatrick scale);
- col. 10 maternal minimum erythema dose (MED), J/m2;
- col. 11 erythemal radiant exposure during pregnancy, mJ/m2;
- col. 12 vitaminal (pre-vitamin D3) radiant exposure during pregnancy, mJ/m2;
- col. 13, 14, 15, 16, 17, 18, 19, 20, 21 relative mRNA gene expression of RXR, VDR, CYP24A1, CYP27B1, TNFalfa, IL-6, IFNgamma, CAMP, CSF-2 (-1 means no data, -2 means no gene amplification, i.e. no gene expression);
- col. 22 level of the 25(OH)D in serum (at enrolment), ng/ml;
- col. 23 level of the 25(OH)D in serum (at delivery), ng/ml;
- col. 24 vitaminal (pre-vitamin D3) radiant exposure during first 90 days of pregnancy, mJ/m2;
- col. 25 vitaminal (pre-vitamin D3) radiant exposure during first 180 days of pregnancy, mJ/m2;
- col. 26 mean vitaminal (pre-vitamin D3) radiant exposure during first 180 days of pregnancy divided by MED;
Additional Information
| Field | Value |
|---|---|
| Last updated | February 14, 2024 |
| Created | October 4, 2023 |
| Format | text/plain |
| Access restriction | Level: Open |